sofwave treatment sagging skin arms glp-1 for Facial Changes: Collagen & Guide Sofwave™ | Affiliated Dermatologists

Now do yours

A study in The New England Journal of Medicine showed that tirzepatide (a dual GLP1/GIP receptor agonist) significantly reduced symptoms of OSA and weight in people with moderate to severe OSA and obesity

Because of their distinct processes and effects, ipamorelin and GHRP-6 differ from other peptides such as hexarelin and CJC-1295

The GLP-1 consumer over-indexes on food and beverage at about 9% higher than the non-user. Circana data shows 5.3% of consumers are actively embracing GLP-1s, and the number may rise to double-digits for those who have at least tried the drug, according to Lyons Wyatt

However, this increase in melanin is not always desired, especially when it leads to conditions like dark spots, melasma, or other forms of skin discoloration